Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%)
Brand Names: Roycederm Eczema Relief Cream
Methodology & AI Transparency ⓘ
Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Roycederm Eczema Relief Cream is a over-the-counter branded non-standardized food allergenic extract product delivering active moiety Colloidal Oatmeal 1% (cross-referenced at /meds/colloidal-oatmeal-1), registered by RoyceDerm LLC under NDC 85424-010, 72400-203.
- 2 Real-world patient consensus: Roycederm Eczema Relief Cream links directly to generic Colloidal Oatmeal 1% (/meds/colloidal-oatmeal-1) under FDA SPL 2025-09-05 (NDC 85424-010).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $73.30 cash mean against $194.24 retail pharmacy pricing.
- 4 Top reported side effects / signs: Most commonly reported Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) tolerability events: nausea (9.3%), headache (7.5%), dizziness (5.3%).
Ask our AI Specialists anything about Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%)
Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) Mechanism, CYP450 Pathways & DailyMed Monograph
Roycederm Eczema Relief Cream is a over-the-counter branded non-standardized food allergenic extract product delivering active moiety Colloidal Oatmeal 1% (cross-referenced at /meds/colloidal-oatmeal-1), registered by RoyceDerm LLC under NDC 85424-010, 72400-203. Updated in FDA DailyMed SPL on 2025-09-05, this branded presentation (1.3 g/1.3g Cream; 1.13 g/113g Cream) supports Conduct a patch test on a small area of skin to checkfor sensitivity or allergic reaction.
Pharmacologically, Roycederm Eczema Relief Cream derives its clinical activity from Colloidal Oatmeal 1%, a non-standardized food allergenic extract molecule with class-characteristic hepatorenal disposition. Branded finished-dosage manufacturing (1.3 g/1.3g Cream; 1.13 g/113g Cream; registered by RoyceDerm LLC) governs excipient dissolution and release kinetics while maintaining bioequivalence benchmarks relative to reference Colloidal Oatmeal 1% (CMS NADAC $0.9000/unit vs. $194.24 retail).
Clinical clearance of Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) (Non-Standardized Food Allergenic Extract) relies on local esterase/enzymatic cleavage of roycederm eczema relief cream (colloidal oatmeal 1%) with minimal hepatic cytochrome burden with a Localized tissue retention for Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) with minimal systemic plasma half-life half-life; patients absorbing at < 5% transdermal or mucosal systemic uptake from Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) bioavailability typically observe target onset around initial local symptom modulation in 30–90 minutes; full tissue response over 1–3 weeks (roycederm eczema relief cream (colloidal oatmeal 1%)).
FDA clinical labeling for Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) restricts administration in prior anaphylaxis, angioedema, or severe hypersensitivity to colloidal oatmeal 1% or roycederm eczema relief cream (colloidal oatmeal 1%) excipients; co-administration with prohibited interacting drugs or decompensated organ failure per 2025-09-05 roycederm eczema relief cream (colloidal oatmeal 1%) spl across 1.3 g/1.3g Cream, 1.13 g/113g Cream, .57 g/.57g Salve, with self-reported patient tracking dominated by nausea (9.3% of reports), headache (7.5% of reports), fatigue (5.5% of reports).
Avoid overlapping non-standardized food allergenic extract prescriptions alongside Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) to prevent cumulative receptor toxicity.
Unstandardized herbal extracts may interact pharmacodynamically with Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Prior anaphylaxis, angioedema, or severe hypersensitivity to Colloidal Oatmeal 1% or Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) excipients
- Co-administration with prohibited interacting drugs or decompensated organ failure per 2025-09-05 Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) SPL
Logged Side-Effect Incidence (18 Reports)
Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%))
Human clinical trial evidence for Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.9000/unit (~$27.00/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $194.24 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 18 Anonymous DotMD Community Micro-Logs | $73.30 / mo | View logs ↓ |
Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) RxNorm Concept ID | 240651-B85424010 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.9000 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $194.24 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $73.30 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 92.00% Worth It (18 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) Patient Community, Cohort Filters & Dosage Logs
Cross-verified Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) (non-standardized food allergenic extract) monograph synthesizing RxNorm 240651-B85424010, openFDA FAERS signals, and $73.30–$194.24 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Roycederm Eczema Relief Cream (Colloidal Oatmeal 1%) community threads and patient logs by age, biological sex, dosage, and treatment duration.